bullish

Pakistan Pharmaceuticals - Listed Pharma Sector Analysis 2024

479 Views09 Apr 2025 14:00
Broker
Pakistan listed pharmaceuticals sector's earnings were up 3.1x to Rs24.8bn in calendar year 2024. This jump in profitability is...
What is covered in the Full Insight:
  • Introduction
  • Earnings Growth in 2024
  • Deregulation Impact
  • Expenses and Financing Costs
  • Outlook and Investment Recommendations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
  • Pakistan Pharmaceuticals - Listed Pharma Sector Analysis 2024
    09 Apr 2025
x